Menu
Currency
GWAS Study

Identification of OCA2 as a novel locus for the co-morbidity of asthma-plus-eczema.

Margaritte-Jeannin P, Budu-Aggrey A, Ege M et al.

34155719 PubMed ID
GWAS Study Type
8807 Participants
47 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

MP
Margaritte-Jeannin P
BA
Budu-Aggrey A
EM
Ege M
MA
Madore AM
LC
Linhard C
MH
Mohamdi H
VM
von Mutius E
GR
Granell R
DF
Demenais F
LC
Laprise C
BE
Bouzigon E
DM
Dizier MH
Chapter II

Abstract

Summary of the research findings

Numerous genes have been associated with the three most common allergic diseases (asthma, allergic rhinitis or eczema) but these genes explain only a part of the heritability. In the vast majority of genetic studies, complex phenotypes such as co-morbidity of two of these diseases, have not been considered. This may partly explain missing heritability.

1,208 European ancestry cases with both asthma and eczema, 7,599 European ancestry controls with neither asthma nor eczema

Chapter III

Study Statistics

Key metrics and study information

8807
Total Participants
GWAS
Study Type
No
Replicated
European
Ancestry
Austria, Germany, Switzerland, U.K.
Recruitment Country
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.